Cardiva Medical Raises $30 Million
Summary
SANTA CLARA, Calif., March 14, 2017 /PRNewswire/ -- Cardiva Medical, an innovator in the field of vascular closure, today announced that the company has completed closing of a $30 million equity financing. "Our mission is focused on reducing access site complications for the millions of patients who undergo vascular procedures each year. VASCADE has made a difference for over 100,000 patients in the United States since commercial launch just three years ago and adoption continues to grow rapidly. "VASCADE has demonstrated an unprecedented safety profile for patients – which is fueling Cardivas rapid growth rate" said Michael Bornitz of Luther King Capital Management. About the VASCADE Vascular Closure System and RESPECT Study There are over 6 million interventional procedures a year in the United States alone, and bleeding at the access site remains the number one source of complications for these patients.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
